QuidelOrtho Overview

  • Year Founded
  • 1937

Year Founded

  • Status
  • Public

  • Employees
  • 6,600

Employees

  • Stock Symbol
  • QDEL

Stock Symbol

  • Investments
  • 13

  • Share Price
  • $28.01
  • (As of Friday Closing)

QuidelOrtho General Information

Description

QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

Contact Information

Formerly Known As
Quidel, Coronado Topco, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 9975 Summers Ridge Road
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 9975 Summers Ridge Road
  • San Diego, CA 92121
  • United States
+1 (858)

QuidelOrtho Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QuidelOrtho Stock Performance

As of 20-Jun-2025, QuidelOrtho’s stock price is $28.01. Its current market cap is $1.9B with 67.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$28.01 $28.33 $23.77 - $49.45 $1.9B 67.6M 1.48M -$4.97

QuidelOrtho Financials Summary

As of 31-Mar-2025, QuidelOrtho has a trailing 12-month revenue of $2.76B.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 4,941,706 5,608,287 7,401,140 8,268,906
Revenue 2,764,700 2,782,900 2,997,800 3,266,000
EBITDA 286,200 (1,492,400) 601,500 1,092,700
Net Income (358,700) (2,052,000) (10,100) 548,700
Total Assets 6,461,600 6,423,600 8,563,100 8,855,800
Total Debt 2,694,200 2,681,400 2,614,100 2,849,100
Public Fundamental Data provided by Morningstar, Inc. disclaimer

QuidelOrtho Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QuidelOrtho‘s full profile, request access.

Request a free trial

QuidelOrtho Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The c
Diagnostic Equipment
San Diego, CA
6,600 As of 2024

Saluggia, Italy
 

Marlborough, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QuidelOrtho Competitors (18)

One of QuidelOrtho’s 18 competitors is DiaSorin, a Formerly PE-Backed company based in Saluggia, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DiaSorin Formerly PE-Backed Saluggia, Italy
Hologic Formerly VC-backed Marlborough, MA
Bio-Rad Laboratories Corporation Hercules, CA
Revvity Corporation Waltham, MA
Great Basin Scientific Formerly VC-backed West Valley City, UT
You’re viewing 5 of 18 competitors. Get the full list »

QuidelOrtho Patents

QuidelOrtho Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240133881-A1 Devices and kits for detecting analytes of interest and methods of using the same Pending 20-Oct-2022
AU-2023289398-A1 System for visualizing and supporting a contextual diagnostic decision for contagious diseases Pending 22-Jun-2022
EP-4544571-A1 System for visualizing and supporting a contextual diagnostic decision for contagious diseases Pending 22-Jun-2022
EP-4515229-A1 Biosensor testing system and methods of use Pending 29-Apr-2022
AU-2022343290-A1 Agglutinating agents, devices and methods for whole blood assays Pending 10-Sep-2021 G01N33/56966
To view QuidelOrtho’s complete patent history, request access »

QuidelOrtho Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QuidelOrtho Investments & Acquisitions (13)

QuidelOrtho’s most recent deal was a Corporate with LEX Diagnostics. The deal was made on 01-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LEX Diagnostics 01-Dec-2023 Corporate Diagnostic Equipment
Developer and Manufacturer of Assays (QuidelOrtho / Shanghai Runda Medical Technology Company) 18-Dec-2022 Joint Venture Diagnostic Equipment
Ortho-Clinical Diagnostics 27-May-2022 Merger/Acquisition Diagnostic Equipment
JRNYS 10-Sep-2021 Later Stage VC Outcome Management (Healthcare)
Alere (facility San Diego) 06-Oct-2017 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

QuidelOrtho ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

24.66 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Healthcare

Industry

of 564

Rank

Percentile

Medical Devices

Subindustry

of 196

Rank

Percentile

To view QuidelOrtho’s complete esg history, request access »

QuidelOrtho Exits (1)

QuidelOrtho’s most recent exit was on 12-Apr-2002 from CymaBay Therapeutics. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
CymaBay Therapeutics 12-Apr-2002 Completed
  • 5 buyers
To view QuidelOrtho’s complete exits history, request access »

QuidelOrtho Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
QuidelOrtho (Transfusion Medicine Unit) San Diego, CA

QuidelOrtho FAQs

  • When was QuidelOrtho founded?

    QuidelOrtho was founded in 1937.

  • Where is QuidelOrtho headquartered?

    QuidelOrtho is headquartered in San Diego, CA.

  • What is the size of QuidelOrtho?

    QuidelOrtho has 6,600 total employees.

  • What industry is QuidelOrtho in?

    QuidelOrtho’s primary industry is Diagnostic Equipment.

  • Is QuidelOrtho a private or public company?

    QuidelOrtho is a Public company.

  • What is QuidelOrtho’s stock symbol?

    The ticker symbol for QuidelOrtho is QDEL.

  • What is the current stock price of QuidelOrtho?

    As of 20-Jun-2025 the stock price of QuidelOrtho is $28.01.

  • What is the current market cap of QuidelOrtho?

    The current market capitalization of QuidelOrtho is $1.9B.

  • What is QuidelOrtho’s current revenue?

    The trailing twelve month revenue for QuidelOrtho is $2.76B.

  • Who are QuidelOrtho’s competitors?

    DiaSorin, Hologic, Bio-Rad Laboratories, Revvity, and Great Basin Scientific are some of the 18 competitors of QuidelOrtho.

  • What is QuidelOrtho’s annual earnings per share (EPS)?

    QuidelOrtho’s EPS for 12 months was -$4.97.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »